Free Trial

CryoPort (CYRX) Competitors

CryoPort logo
$7.19 -0.24 (-3.23%)
Closing price 04:00 PM Eastern
Extended Trading
$7.29 +0.10 (+1.39%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CYRX vs. TVTX, EWTX, EVO, BHVN, MESO, ANIP, HROW, PAHC, ABCL, and COGT

Should you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Travere Therapeutics (TVTX), Edgewise Therapeutics (EWTX), Evotec (EVO), Biohaven (BHVN), Mesoblast (MESO), ANI Pharmaceuticals (ANIP), Harrow (HROW), Phibro Animal Health (PAHC), AbCellera Biologics (ABCL), and Cogent Biosciences (COGT). These companies are all part of the "pharmaceutical products" industry.

CryoPort vs. Its Competitors

Travere Therapeutics (NASDAQ:TVTX) and CryoPort (NASDAQ:CYRX) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Travere Therapeutics has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.89, indicating that its stock price is 89% more volatile than the S&P 500.

92.9% of CryoPort shares are owned by institutional investors. 4.2% of Travere Therapeutics shares are owned by insiders. Comparatively, 10.0% of CryoPort shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CryoPort has a net margin of -50.15% compared to Travere Therapeutics' net margin of -82.88%. CryoPort's return on equity of -11.03% beat Travere Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Travere Therapeutics-82.88% -1,179.73% -41.10%
CryoPort -50.15%-11.03%-5.54%

CryoPort has lower revenue, but higher earnings than Travere Therapeutics. Travere Therapeutics is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Travere Therapeutics$233.18M6.14-$321.55M-$2.81-5.73
CryoPort$228.38M1.58-$114.76M-$2.34-3.07

In the previous week, Travere Therapeutics had 8 more articles in the media than CryoPort. MarketBeat recorded 12 mentions for Travere Therapeutics and 4 mentions for CryoPort. CryoPort's average media sentiment score of 1.21 beat Travere Therapeutics' score of 0.44 indicating that CryoPort is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Travere Therapeutics
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
CryoPort
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Travere Therapeutics currently has a consensus target price of $32.14, suggesting a potential upside of 99.52%. CryoPort has a consensus target price of $10.88, suggesting a potential upside of 51.25%. Given Travere Therapeutics' stronger consensus rating and higher possible upside, research analysts clearly believe Travere Therapeutics is more favorable than CryoPort.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Travere Therapeutics
0 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.87
CryoPort
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

CryoPort beats Travere Therapeutics on 10 of the 16 factors compared between the two stocks.

Get CryoPort News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYRX vs. The Competition

MetricCryoPortTRANS IndustryTransportation SectorNASDAQ Exchange
Market Cap$372.52M$5.74B$7.32B$9.41B
Dividend YieldN/A2.30%922.82%4.03%
P/E Ratio-3.079.5612.3320.09
Price / Sales1.581.19543.5099.01
Price / CashN/A10.717.9158.27
Price / Book0.972.942.135.65
Net Income-$114.76M$184.70M$568.35M$257.91M
7 Day Performance-4.77%-2.35%-1.23%2.09%
1 Month Performance6.05%0.24%3.59%11.13%
1 Year Performance-15.51%-6.40%3.13%18.40%

CryoPort Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYRX
CryoPort
2.4035 of 5 stars
$7.19
-3.2%
$10.88
+51.3%
-12.3%$372.52M$228.38M-3.071,186Analyst Revision
TVTX
Travere Therapeutics
3.7272 of 5 stars
$16.91
+2.7%
$32.14
+90.1%
+60.4%$1.50B$233.18M-6.02460News Coverage
Analyst Revision
EWTX
Edgewise Therapeutics
1.4953 of 5 stars
$13.93
+0.7%
$40.00
+187.2%
-36.1%$1.47BN/A-8.9960
EVO
Evotec
1.9928 of 5 stars
$4.12
+1.2%
$5.93
+44.0%
-11.3%$1.46B$862.40M0.004,827Gap Up
BHVN
Biohaven
3.3597 of 5 stars
$14.18
+1.8%
$58.46
+312.2%
-58.2%$1.45BN/A-1.52239Trending News
MESO
Mesoblast
1.6926 of 5 stars
$11.17
+0.5%
$18.00
+61.1%
+67.2%$1.43B$5.90M0.0080News Coverage
Positive News
Analyst Downgrade
Gap Up
ANIP
ANI Pharmaceuticals
3.7657 of 5 stars
$65.19
+0.4%
$78.88
+21.0%
+8.0%$1.41B$674.07M-51.33600
HROW
Harrow
2.3814 of 5 stars
$35.62
+2.0%
$63.83
+79.2%
+43.7%$1.31B$199.61M-63.61180Trending News
Analyst Revision
PAHC
Phibro Animal Health
4.0498 of 5 stars
$31.54
+2.4%
$24.40
-22.6%
+56.3%$1.28B$1.02B40.441,940News Coverage
ABCL
AbCellera Biologics
2.3189 of 5 stars
$4.24
+5.7%
$8.75
+106.4%
+15.7%$1.27B$28.83M-7.57500
COGT
Cogent Biosciences
3.5461 of 5 stars
$11.09
+1.0%
$18.00
+62.3%
+35.9%$1.26BN/A-6.0380Trending News
Analyst Forecast
Analyst Revision
Gap Up

Related Companies and Tools


This page (NASDAQ:CYRX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners